Shraddha Institute of Pharmacy, Kondala Zambre, Washim - 444505.
Asthma is a chronic inflammatory respiratory disorder characterized by airway hyperresponsiveness, mucosal inflammation, and reversible airflow obstruction. Inhaled corticosteroids such as Beclomethasone, Budesonide, and Fluticasone remain the cornerstone of asthma management; however, their prolonged use is associated with local and systemic adverse effects including throat irritation, immunosuppression, adrenal suppression, and mucosal dryness, which may reduce patient compliance and quality of life.The present study aims to formulate and evaluate a herbal aromagel as a complementary therapeutic approach to mitigate corticosteroid-induced adverse effects while supporting respiratory health. The formulation incorporates bioactive herbal constituents such as Ginseng, Asperuloside, and Eriodictyol, known for their anti-inflammatory, antioxidant, bronchodilatory, and immunomodulatory properties.The aromagel is designed as a semi-solid topical system that enables both transdermal absorption and inhalation of volatile compounds, providing dual therapeutic action. Physicochemical parameters including pH, viscosity, spreadability, and stability were evaluated. Phytochemical screening was performed to confirm the presence of active constituents, and safety assessment included skin irritation studies.The results suggest that the herbal aromagel possesses desirable physicochemical characteristics and demonstrates potential in reducing inflammation, oxidative stress, and airway reactivity. The synergistic action of herbal components may help counteract the adverse effects associated with long-term corticosteroid therapy.This study highlights the potential of herbal aromagel as a novel, safe, and effective adjunctive therapy for improving respiratory health and enhancing patient compliance in asthma management.
Asthma is a chronic inflammatory respiratory disorder commonly treated with inhaled corticosteroids such as Beclomethasone, Budesonide, and Fluticasone. Although effective, prolonged use of these drugs may lead to adrenal suppression and immune suppression, resulting in fatigue, stress intolerance, and increased susceptibility to infections.
Asthma is a long-term condition marked by persistent inflammation in the airways. Various types of immune and structural cells, such as mast cells, eosinophills, T cells, macrophages, neutrophills, and epithelial cells, are involved in the disease process. In individuals who are susceptible, this inflammation leads to repeated episodes of symptoms like wheezing, shortness of breath, chest tightness, and coughing, especially during the night or early morning hours. These flare-ups are commonly linked to widespread but changeable narrowing of the airways, which can typically improve either on its own or with medical intervention. The underlying inflammation also increases the sensitivity of the airways to different triggers. While many individuals experience full reversal of airflow limitation, in some cases, this reversal may be only partial.
Adverse effects of inhaled corticosteroids and their causes:
Inhaled corticosteroids used in asthma, such as beclomethasone dipropionate can produce both local and systemic adverse effects due to their pharmacological action and site of deposition. Local airway irritation may occur when drug particles deposit on the trachea, bronchi, and larynx, causing cough, throat irritation, hoarseness, and sometimes paradoxical bronchospasm due to reflex activation of airway sensory nerves. Local immunosuppression in the oral and pharyngeal mucosa reduces host defense mechanisms, leading to infections such as oral candidiasis and increased susceptibility to respiratory infections. Deposition of corticosteroids on the laryngeal muscles can result in steroid-induced myopathy, causing voice changes and dysphonia. With long-term or high-dose use, a portion of the drug may be systemically absorbed, suppressing the hypothalamic pituitary adrenal axis through negative feedback inhibition of cortisol secretion, which can lead to adrenal suppression and reduced stress response.Although effective, long-term corticosteroid therapy is associated with adverse effects including throat irritation, immune suppression, adrenal suppression, mucosal dryness, cough, and paradoxical bronchospasm. These side effects reduce patient compliance and quality of life.
Herbal Aromagel
An aromagel is a semi-solid topical gel formulation containing volatile aromatic compounds and herbal extracts, designed to release therapeutic vapors for inhalation while also allowing local transdermal absorption. It combines the advantages of aromatherapy and gel-based drug delivery.
Herbal aromatherapy offers a complementary approach by delivering volatile bioactive compounds through inhalation and topical absorption, producing rapid local and systemic effects. Medicinal plants such as Thyme, Menthol, Ginger, Licorice, Ginseng, Basil (Tulsi) and bioactive compounds like Asperuloside and Eriodictyol possess anti-inflammatory, bronchodilatory, antioxidant, immunomodulatory, and mucoprotective properties. Incorporating these agents into a herbal aromatherapy gel may help counteract corticosteroid-induced adverse effects while supporting respiratory health.
These bioactive compounds interact with multiple cellular and molecular targets, modulating signaling pathways involved in inflammation, oxidative stress, and immune responses. The inhaled volatile agents directly affect the airway mucosa and smooth muscle, promoting bronchodilation and reducing inflammation, while the transdermally absorbed compounds contribute to systemic immunomodulation and tissue repair. Additionally, the antioxidant properties of these compounds help neutralize reactive oxygen species generated during respiratory diseases or corticosteroid therapy, thereby protecting lung tissues from oxidative damage. The synergistic action of diverse herbal constituents in the gel matrix not only supports respiratory function but also offers a complementary approach to counteract the adverse effects of long-term corticosteroid use, such as mucosal thinning and immune suppression. Theoretically, aromagels represent an innovative platform that integrates phytochemical complexity with advanced drug delivery principles, optimizing therapeutic efficacy while minimizing systemic side effects. Through controlled vapor release and skin absorption, aromagels provide a holistic and multifaceted means to support respiratory health, reduce inflammation, and enhance overall well-being.
MATERIAL AND METHODOLOGY
Materials
Eriodictyol and asperuloside were used as primary active phytoconstituents. The herbal materials selected included ginger (Zingiber officinale), ginseng (Panax ginseng), licorice (Glycyrrhiza glabra), basil (Ocimum basilicum), and thyme (Thymus vulgaris), based on their reported anti-inflammatory, bronchodilatory, and antioxidant properties.
Carbopol 940 was used as a gelling agent, Polysorbate 20 as a solubilizing agent, and propyl paraben as a preservative. Purified water was used as the vehicle. All chemicals and reagents used were of analytical grade and obtained from authenticated suppliers.
Methodology
1. Preparation of Herbal Extracts
The crude plant materials were washed, shade-dried, and coarsely powdered. The powdered drugs were subjected to maceration using hydroalcoholic solvent (ethanol:water, 70:30) for 48-72 hours with occasional stirring. The extracts were filtered using muslin cloth followed by Whatman filter paper and concentrated using a water bath at controlled temperature (40-50°C). The concentrated extracts were stored in airtight containers for further use.
2. Preparation of Carbopol Gel Base
Carbopol 940 was pre-wetted with a small amount of glycerin to prevent clumping and then dispersed in purified water under continuous stirring. The dispersion was allowed to hydrate completely to form a uniform gel base. Air bubbles entrapped during mixing were removed by gentle sonication. The gel base was stored in a closed container to prevent contamination.
3. Incorporation of Herbal Extracts and Essential Oils
The prepared herbal extracts and essential oils were added gradually to the gel base with continuous gentle stirring to ensure uniform distribution. Compatibility of ingredients was confirmed by observing any phase separation or precipitation. Care was taken to avoid excessive stirring to prevent foam formation.
4. Final Adjustment and Homogenization
The formulation was homogenized using a mechanical homogenizer to obtain a smooth and uniform consistency. The pH of the gel was adjusted and maintained within the suitable range (6.5-7.0). The formulation was evaluated for uniformity and absence of aggregates.
5. Filling and Packaging
The final gel was filled into suitable containers under hygienic conditions. Proper packaging materials were selected to protect the formulation from light, moisture, and contamination. The containers were labeled with batch number, manufacturing date, expiry date, and storage instructions, and stored under controlled condition
6. Preformulation Studies
Preformulation studies of herbal extracts were carried out to determine:
Ingredients of Herbal Aromagel
Table 1 : Ingredients used in Herbal aromagel
|
Sr.No |
Name of Material |
Type |
Purpose |
|
1 |
Eriodictyol |
Active Ingredient |
Provides antioxidant activity which protects airway tissues |
|
2 |
Asperuloside |
Active Ingredient |
Helps in healing irritated mucosa |
|
3 |
Ginger |
Active Ingredient |
Provides anti-inflammatory effect |
|
4 |
Ginseng |
Active Ingredient |
Provides immunomodulatory effect |
|
5 |
Licorice |
Active Ingredient |
Provides soothing effect |
|
6 |
Basil |
Active Ingredient |
Supports lung function |
|
7 |
Thyme |
Active Ingredient |
Provides expectorant action |
|
8 |
Carbopol 940 |
Gelling Agent |
Gelling agent that gives structure to the formulation |
|
9 |
Polysorbate 20 |
Solubilizer |
Solubilizer |
|
10 |
Propyl Paraben |
Preservative |
Preservative to prevent microbial growth |
|
11 |
Purified Water |
Vehicle |
Solvent and base for gel preparation |
Formulation of Herbal Aromagel
Table No 2 : Formulation Table
|
Sr.No |
Ingredients |
F1 |
F2 |
F3 |
Function |
|
1 |
Eriodictyol Extract |
0.02 ml |
0.03 ml |
0.03 ml |
Antioxidant |
|
2 |
Asperuloside Extract |
0.03 ml |
0.03 ml |
0.03 ml |
Anti-inflammatory action |
|
3 |
Ginger Extract |
0.08 ml |
0.07 ml |
0.08 ml |
Bronchial relief |
|
4 |
Ginseng Extract |
0.08 ml |
0.08 ml |
0.08 ml |
Immune support |
|
5 |
Licorice Extract |
0.08 ml |
0.09 ml |
0.08 ml |
Mucosal soothing |
|
6 |
Basil Extract |
0.05 ml |
0.06 ml |
0.05 ml |
Antimicrobial action |
|
7 |
Thyme Extract |
0.04 ml |
0.05 ml |
0.05 ml |
Antifungal action |
|
8 |
Carbopol 940 |
0.5 gm |
0.5 gm |
0.5 gm |
Gelling agent |
|
9 |
Polysorbate 20 |
0.1 gm |
0.1 gm |
0.1 gm |
Solubilizing agent |
|
10 |
Propyl Paraben |
0.01 gm |
0.01 gm |
0.01 gm |
Preservative |
Evaluation Parameters
Evaluation Parameters
Table No. 3 : Evaluation parameter
|
Sr.No |
Test |
Result |
|
1 |
Colour |
Pale yellow to brown |
|
2 |
Odour |
Aromatic |
|
3 |
Texture |
Smooth |
|
4 |
Constistency |
Semi-solid |
The pH of the formulated aromagel was measured using a calibrated pH meter and found to be
6.5.
The ideal pH of skin is 5.5 to 7.0.
Figure No 1 : pH Test
The herbal aromagel demonstrated excellent spreadability, allowing it to be evenly and smoothly applied over the skin surface with minimal effort. When a small amount of gel was placed between two glass slides, it spread uniformly without breaking or forming lumps, indicating good flow properties. This facilitated easy coverage of the affected area, enhancing user comfort and ensuring efficient delivery of the herbal actives. The balanced viscosity and non-sticky nature of the gel contributed to its superior spreadability, making it suitable for regular topical use.
Procedure:
Figure No 2 : Spreadability Test
Washability refers to how the gel can be removed from the skin using water. This is important for user convenience and hygiene especially for products used multiple times a da or over large skin areas.
Procedure:
Before wash After wash
Figure No 3 : Washability Test
RESULT AND DISCUSSION
The formulated herbal aromagel was successfully prepared and evaluated for various physicochemical and organoleptic parameters. The results obtained indicate that the formulation possesses desirable characteristics suitable for topical application and aromatherapeutic use.
CONCLUSION
The formulation of the herbal aromagel aimed to provide a natural and effective alternative to mitigate the adverse effects associated with prolonged corticosteroid use in asthma patients. It incorporated carefully selected herbal extracts known for their anti-inflammatory, bronchodilatory, antioxidant, and immunomodulatory properties, which were intended to complement conventional treatment by addressing inflammation, improving airway function, and supporting immune resilience. The choice of these herbs was based on their traditional medicinal use as well as scientific evidence supporting their therapeutic benefits in respiratory health.
The evaluation process focused extensively on ensuring the gel’s stability, safety, and efficacy through a series of physicochemical and sensory tests. Parameters such as pH, viscosity, texture, spreadability, and odor were meticulously assessed to confirm the product’s suitability for topical application and patient acceptability. Stability studies under various storage conditions were conducted to verify that the formulation maintained its physical integrity and biological activity over time. Additionally, microbial testing was performed to ensure the safety and preservative effectiveness within the gel matrix.
The herbal aromagel was intended to serve as a complementary therapeutic option that could support respiratory health, enhance patient compliance, and improve the overall quality of life for individuals managing asthma. By offering a natural, topical alternative, the formulation aimed to reduce common corticosteroid-related side effects such as throat irritation, immune suppression, and increased infection risk. This, in turn, was expected to encourage better adherence to asthma treatment regimens.
Future perspectives included validating the formulation’s therapeutic efficacy and safety through rigorous in vitro and in vivo studies, including clinical trials. These studies would provide critical data to support the aromagel’s role as a valuable adjunct in asthma management. Ultimately, the project envisioned that this herbal aromagel could be integrated into standard treatment protocols, providing patients with a holistic approach that combines the benefits of herbal medicine with modern pharmacotherapy to achieve improved respiratory health outcomes.
REFERENCES
Gayatri Bhale, Amruta Bawane, Dr. S. Deshmukh, Formulation And Evaluation of Herbal Aromagel Against Steroid-Induced Adverse Effects in Asthma, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 4, 3905-3912, https://doi.org/10.5281/zenodo.19706958
10.5281/zenodo.19706958